Contineum Therapeutics, Inc. Quarterly Assets in USD from Q4 2023 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Contineum Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2023 to Q4 2024.
Contineum Therapeutics, Inc. Assets for the quarter ending December 31, 2024 was $213M, a 63.2% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$213M	+$82.5M	+63.2%	Dec 31, 2024	10-K	2025-03-06
Q3 2024	$216M			Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$221M			Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$124M			Mar 31, 2024	10-Q	2024-05-16
Q4 2023	$130M			Dec 31, 2023	10-K	2025-03-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.